Cargando…
Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution
BACKGROUND: People report using cannabis as a substitute for prescription medications but may be doing so without the knowledge of their primary health care providers (PCPs). This lack of integration creates serious concerns, e.g., using cannabis to treat medical conditions that have established tre...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831240/ https://www.ncbi.nlm.nih.gov/pubmed/33526140 http://dx.doi.org/10.1186/s42238-021-00058-0 |
_version_ | 1783641595160035328 |
---|---|
author | Boehnke, Kevin F. Litinas, Evangelos Worthing, Brianna Conine, Lisa Kruger, Daniel J. |
author_facet | Boehnke, Kevin F. Litinas, Evangelos Worthing, Brianna Conine, Lisa Kruger, Daniel J. |
author_sort | Boehnke, Kevin F. |
collection | PubMed |
description | BACKGROUND: People report using cannabis as a substitute for prescription medications but may be doing so without the knowledge of their primary health care providers (PCPs). This lack of integration creates serious concerns, e.g., using cannabis to treat medical conditions that have established treatment options. METHODS: We conducted an anonymous, cross-sectional online survey among patrons of a medical cannabis dispensary in Michigan (n = 275) to examine aspects of their relationship with their PCP and their perceptions of PCP knowledge related to cannabis. RESULTS: Overall, 64% of participants initiated medical cannabis use based on their own experiences vs. 24% citing advice from their PCP. Although 80% reported that their PCP knew they currently used medical cannabis, 41% reported that their PCP had not always known. Only 14% obtained their medical cannabis authorization from their PCP. Only 18% of participants rated their PCP’s knowledge about medical cannabis as very good or excellent and only 21% were very or completely confident in their PCP’s ability to integrate medical cannabis into their treatment. Although 86% had substituted cannabis for pharmaceutical medications, 69% (n = 134) of those who substituted reported some gap in their PCP’s knowledge of their substitution, and 44% (n = 86) reported that their PCP was currently unaware of their substitution. CONCLUSIONS: Patients frequently substitute cannabis for prescription drugs, often without PCP knowledge. Although most participants disclosed cannabis use to their PCP, their perceptions of PCP knowledge ranged widely and many obtained medical cannabis licensure from an outside physician. Our results highlight the need for standardized physician education around appropriate medical cannabis use. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s42238-021-00058-0. |
format | Online Article Text |
id | pubmed-7831240 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-78312402021-01-25 Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution Boehnke, Kevin F. Litinas, Evangelos Worthing, Brianna Conine, Lisa Kruger, Daniel J. J Cannabis Res Original Research BACKGROUND: People report using cannabis as a substitute for prescription medications but may be doing so without the knowledge of their primary health care providers (PCPs). This lack of integration creates serious concerns, e.g., using cannabis to treat medical conditions that have established treatment options. METHODS: We conducted an anonymous, cross-sectional online survey among patrons of a medical cannabis dispensary in Michigan (n = 275) to examine aspects of their relationship with their PCP and their perceptions of PCP knowledge related to cannabis. RESULTS: Overall, 64% of participants initiated medical cannabis use based on their own experiences vs. 24% citing advice from their PCP. Although 80% reported that their PCP knew they currently used medical cannabis, 41% reported that their PCP had not always known. Only 14% obtained their medical cannabis authorization from their PCP. Only 18% of participants rated their PCP’s knowledge about medical cannabis as very good or excellent and only 21% were very or completely confident in their PCP’s ability to integrate medical cannabis into their treatment. Although 86% had substituted cannabis for pharmaceutical medications, 69% (n = 134) of those who substituted reported some gap in their PCP’s knowledge of their substitution, and 44% (n = 86) reported that their PCP was currently unaware of their substitution. CONCLUSIONS: Patients frequently substitute cannabis for prescription drugs, often without PCP knowledge. Although most participants disclosed cannabis use to their PCP, their perceptions of PCP knowledge ranged widely and many obtained medical cannabis licensure from an outside physician. Our results highlight the need for standardized physician education around appropriate medical cannabis use. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s42238-021-00058-0. BioMed Central 2021-01-24 /pmc/articles/PMC7831240/ /pubmed/33526140 http://dx.doi.org/10.1186/s42238-021-00058-0 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Research Boehnke, Kevin F. Litinas, Evangelos Worthing, Brianna Conine, Lisa Kruger, Daniel J. Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution |
title | Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution |
title_full | Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution |
title_fullStr | Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution |
title_full_unstemmed | Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution |
title_short | Communication between healthcare providers and medical cannabis patients regarding referral and medication substitution |
title_sort | communication between healthcare providers and medical cannabis patients regarding referral and medication substitution |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831240/ https://www.ncbi.nlm.nih.gov/pubmed/33526140 http://dx.doi.org/10.1186/s42238-021-00058-0 |
work_keys_str_mv | AT boehnkekevinf communicationbetweenhealthcareprovidersandmedicalcannabispatientsregardingreferralandmedicationsubstitution AT litinasevangelos communicationbetweenhealthcareprovidersandmedicalcannabispatientsregardingreferralandmedicationsubstitution AT worthingbrianna communicationbetweenhealthcareprovidersandmedicalcannabispatientsregardingreferralandmedicationsubstitution AT coninelisa communicationbetweenhealthcareprovidersandmedicalcannabispatientsregardingreferralandmedicationsubstitution AT krugerdanielj communicationbetweenhealthcareprovidersandmedicalcannabispatientsregardingreferralandmedicationsubstitution |